Large Cap Archives - Page 50 of 437

2 minute read

Boeing’s 737 Saga Dents Q1 Bottomline, CEO Emphasizes Improving Quality & Safety

April 24, 9:22 AM

Boeing reported Q1 results, emphasizing commitment to quality and safety. Revenue declined 8% to $16.569B, adjusted loss per share $(1.13), backlog $529B, and debt $47.9B.

2 minute read

Patient Data Compromised – UnitedHealth Group Admits Ransom Payment in Cyberattack

By Vandana Singh

April 23, 3:09 PM

UnitedHealth Group disclosed ransom payments after the cyberattack on Change Healthcare. Breach exposes personal data, impacting millions. The company cooperates with law enforcement for a thorough investigation.

UNH

1 minute read

FDA Approves Novartis’ Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors

By Vandana Singh

April 23, 3:05 PM

Discover Novartis' FDA approval for Lutathera in pediatric patients with GEP-NETs, marking a pivotal milestone in treating this rare cancer. Explore its efficacy in combating SSTR+ tumors, backed by robust trial data.

NVS

2 minute read

Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends

By Vandana Singh

April 23, 3:03 PM

Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow.

INCY

2 minute read

Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown

By Vandana Singh

April 23, 3:00 PM

Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.

BNTX

3 minute read

Who’s Winning In Weed? Analyst Looks At Cannabis Market’s Big Players, Where Are The Best Bets?

By Nicolas Jose Rodriguez

April 23, 2:08 PM

In the first quarter of 2024, the cannabis sector faces a mixed economic landscape with a notable sequential decline in sales across several states.

AAWH

1 minute read

RTX Soars Above Estimates in Q1, Reiterates FY24 Outlook

By Lekha Gupta

April 23, 1:49 PM

RTX Corporation (NYSE: RTX) reported 12% increase in Q1 FY24 net sales to $19.3 billion, beating consensus. Collins Aerospace and Pratt & Whitney drove the growth.

RTX

2 minute read

What’s Going On With Freeport-McMoRan Shares Today?

By Lekha Gupta

April 23, 1:35 PM

Freeport-McMoRan reports Q1 FY24 results, beats expectations in revenue and adjusted EPS. Copper and gold sales increase.

COPP

2 minute read

Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What’s Driving Markets Tuesday?

By Piero Cingari

April 23, 1:33 PM

Stocks surged as weak economic data raised hopes for Fed rate cut. S&P 500 up 1.2%, Nasdaq 100 up 1.5%, Dow Jones up 0.6%. Spotify shares jump 17% on earnings.

BKR

2 minute read

Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder

By Vandana Singh

April 23, 1:28 PM

Neurocrine Biosciences reports Phase 2 data for NBI-1065845 in major depressive disorder. Results show significant improvement in MADRS scores. William Blair sees the potential for $1 billion+ in sales.

NBIX